MCD and KO Related Headlines
Go Back- Dozens of stocks on watch after Novo Nordisk raises guidance on weight loss drug strength
- New GLP-1 obesity drugs could have broad impacts, analysts say
- U.S. stocks are rising ahead of more earnings reports and the Fed's rate decision
